Moreover, a high level of TGF-β is observed in the EVs of AML patients upon diagnosis, which is dramatically reduced following chemotherapy, suggesting that EVs’ TGF-β levels mark the effect of chemotherapy in AML [189]. This evidence concerns the gene TGFB1 and acute myeloid leukemia.